Work in the medical field is going to be done in a number of different ways and typical procedures, at least the first few times around, are done with mice. They are able to react to certain treatments in particular ways, which gives a good idea of how humans are going to react to certain therapies. That being said, how can brain tumor research expand in such a way? It's a point to take into account and a recent story on the matter was successful in grabbing my attention.
According to Science Daily, John Hopkins researchers have been working hard to see how mice react to a certain FDA-approved drug. However, in order to make this viable in the field of brain tumor research, the mice were treated as they had human tumor cells in their bodies. What's even more interesting than this is that the drug showed a halting of such tumors and there was no trace to be found as well. To say that this story deserves the attention of organizations like Voices against Brain Cancer would be an understatement.
The story spoke about the IDH1 gene in particular, which was expanded upon back in 2008. This particular gene is seen in 70 to 80 percent of tumors and it is oftentimes mutated. One of the things to take into account is that, with said mutation brought into effect, the brain may not be able to put glucose to use, meaning that the energy typically brought from it cannot be utilized. As you can see, there are challenges to be had in this level of research.
It seems like tumor types are going to shift around in terms of details, whether you realize this to be true or not. After all, keep in mind that there may be many types of growths, some of them obvious more common than others. After all, gliomas are seen as some of the most common, which is arguably why most studies have focused on them more so than any other variant. It's apparent that tumors of all types are going to be looked at within the medical field as well.
In my eyes, brain tumor research is one of those fields that have so much attention brought to it for the right reasons. Finding solid cures has proven to be a challenge but therapies seem to be built more and more over the course of time. It seems like some of them have proven to be successful, which has the case with this particular trial. Whether or not this will translate into human use remains to be seen but I am confident that results will rise to the surface.
According to Science Daily, John Hopkins researchers have been working hard to see how mice react to a certain FDA-approved drug. However, in order to make this viable in the field of brain tumor research, the mice were treated as they had human tumor cells in their bodies. What's even more interesting than this is that the drug showed a halting of such tumors and there was no trace to be found as well. To say that this story deserves the attention of organizations like Voices against Brain Cancer would be an understatement.
The story spoke about the IDH1 gene in particular, which was expanded upon back in 2008. This particular gene is seen in 70 to 80 percent of tumors and it is oftentimes mutated. One of the things to take into account is that, with said mutation brought into effect, the brain may not be able to put glucose to use, meaning that the energy typically brought from it cannot be utilized. As you can see, there are challenges to be had in this level of research.
It seems like tumor types are going to shift around in terms of details, whether you realize this to be true or not. After all, keep in mind that there may be many types of growths, some of them obvious more common than others. After all, gliomas are seen as some of the most common, which is arguably why most studies have focused on them more so than any other variant. It's apparent that tumors of all types are going to be looked at within the medical field as well.
In my eyes, brain tumor research is one of those fields that have so much attention brought to it for the right reasons. Finding solid cures has proven to be a challenge but therapies seem to be built more and more over the course of time. It seems like some of them have proven to be successful, which has the case with this particular trial. Whether or not this will translate into human use remains to be seen but I am confident that results will rise to the surface.
About the Author:
Visit Voices Against Brain Cancer if you're searchingfor more information about glioblastoma research.
0 comments:
Post a Comment